Stiff man syndrome (SMS), an uncommon neurological disease, is characterised by symmetrical muscle stiffness and spasms that often lead to skeletal deformity. Variants of the syndrome may involve one limb only (stiff leg syndrome), a variety of additional neurological symptoms and signs such as eye movement disturbances, ataxia, or Babinski signs (progressive encephalomyelitis with rigidity and myoclonus), or be associated with malignant disease (paraneoplastic SMS). Antineuronal autoimmunity and accompanying autoimmune diseases, most often insulin-dependent diabetes mellitus, are characteristic features of SMS and its variants. The condition is frequently misinterpreted as psychogenic movement disturbance, but electromyographic abnormalities and the presence of autoantibodies against glutamic acid decarboxylase (GAD) in both serum and cerebrospinal fluid help to establish the correct diagnosis.
The aetiology of SMS is obscure. However, several features suggest that SMS is an autoimmune-mediated chronic encephalomyelitis. In line with this hypothesis, immunomodulation with a front-loaded methylprednisolone regimen reduces stiffness and spasms and improves other neurological symptoms in the majority of patients. Plasmapheresis or intravenous immunoglobulins are effective less frequently. For symptomatic treatment, the benzodiazepines are drugs of first choice. An alternative of last resort is baclofen administered intrathecally via an implanted pump device.
KeywordsBaclofen Glutamic Acid Decarboxylase Hereditary Spastic Paraplegia Tizanidine Intrathecal Baclofen
This work was generously supported by the Volkswagenstiftung. No other sources of funding were used.
- 1.Moersch F, Woltman HW. Progressive fluctuating muscular rigidity and spasms (‘stiff-man’ syndrome): report of a case and some observations in 13 other cases. Mayo Clin Proc 1956; 31: 421–7Google Scholar
- 8.Asher R. A woman with the stiff-man syndrome. BMJ 1958: 265–6Google Scholar
- 33.Mugnaini E, Oertel WH. An atlas on the distribution of GABA-ergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy. Vol. 4. Amsterdam: Elsevier, 1985: 436–608Google Scholar
- 41.Meinck HM, Tronnier V, Marquardt G. Surgical treatment of stiff-man syndrome with intrathecal baclofen. In: Krauss J, Jankovic J, Grossman RG, editors. Movement disorders surgery. Philadelphia (PA): Lippincott, Williams & Wilkins, 2001: 393–6Google Scholar
- 44.Meinck H-M. Immunomodulation in the stiff man syndrome [abstract]. Mov Disord 2000; 15: 252Google Scholar